Ophthalmology

The first gene therapy for hereditary retinal disease, voretigene neparvovec or Luxturna, has recently been approved for use. UZ Leuven doctors have treated a first patient with this new type of gene therapy. If diagnosed in time, Luxturna can prevent further progression of the disorder.

Researchers at UZ Leuven, KU Leuven, VITO and imec have published promising results on the use of a hyperspectral camera to detect protein plaques in the eyes of Alzheimer's patients.

UZ Leuven is currently running one for the first European large-scale trials into the micro-organisms that live on our ocular surface. Researchers hope to get a better insight in specific eye disorders.